(Q28208650)
Statements
Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study (English)
0 references
4 December 2001
0 references
104
0 references
23
0 references
2778-83
0 references